These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 12651280)
1. Simultaneous expression of CD38 and its ligand CD31 by chronic lymphocytic leukemia B-cells: anecdotal observation or pathogenetic hypothesis for the clinical outcome? Morabito F; Mangiola M; Stelitano C; Deaglio S; Callea V; Malavasi F Haematologica; 2003 Mar; 88(3):354-5. PubMed ID: 12651280 [No Abstract] [Full Text] [Related]
2. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia. Ibrahim S; Jilani I; O'Brien S; Rogers A; Manshouri T; Giles F; Faderl S; Thomas D; Kantarjian H; Keating M; Albitar M Cancer; 2003 Apr; 97(8):1914-9. PubMed ID: 12673718 [TBL] [Abstract][Full Text] [Related]
3. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients. Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155 [TBL] [Abstract][Full Text] [Related]
4. HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses. Scielzo C; Ghia P; Conti A; Bachi A; Guida G; Geuna M; Alessio M; Caligaris-Cappio F J Clin Invest; 2005 Jun; 115(6):1644-50. PubMed ID: 15931393 [TBL] [Abstract][Full Text] [Related]
5. Bimodal cell populations are common in chronic lymphocytic leukemia but do not impact overall survival. Cocco AE; Osei ES; Thut DM; Edinger AK; Powers JJ; Fu P; Meyerson HJ Am J Clin Pathol; 2005 Jun; 123(6):818-25. PubMed ID: 15899771 [TBL] [Abstract][Full Text] [Related]
6. Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil. Morabito F; Mangiola M; Stelitano C; Deaglio S; Callea V; Malavasi F Haematologica; 2002 Feb; 87(2):217-8. PubMed ID: 11836173 [TBL] [Abstract][Full Text] [Related]
8. Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: correlation with CD38 expression. Ottaggio L; Viaggi S; Zunino A; Zupo S; Rossi E; Spriano M; Abbondandolo A; Ferrarini M Haematologica; 2003 Jul; 88(7):769-77. PubMed ID: 12857555 [TBL] [Abstract][Full Text] [Related]
9. The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience. Gentile M; Mauro FR; Calabrese E; De Propris MS; Giammartini E; Mancini F; Milani ML; Guarini A; Foà R Br J Haematol; 2005 Aug; 130(4):549-57. PubMed ID: 16098069 [TBL] [Abstract][Full Text] [Related]
10. The use of CD38 expression by monoclonal B lymphocytes as a prognostic factor in B-cell chronic lymphocytic leukemia. Boonstra JG; von't Veer MB; Gratama JW J Biol Regul Homeost Agents; 2004; 18(3-4):340-6. PubMed ID: 15786702 [TBL] [Abstract][Full Text] [Related]
11. CD38 modifications in chronic lymphocytic leukemia: are they relevant? Ghia P; Guida G; Scielzo C; Geuna M; Caligaris-Cappio F Leukemia; 2004 Oct; 18(10):1733-5. PubMed ID: 15343349 [No Abstract] [Full Text] [Related]
12. CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia. Dürig J; Naschar M; Schmücker U; Renzing-Köhler K; Hölter T; Hüttmann A; Dührsen U Leukemia; 2002 Jan; 16(1):30-5. PubMed ID: 11840260 [TBL] [Abstract][Full Text] [Related]
14. CD31 density is a novel risk factor for patients with B-cell chronic lymphocytic leukaemia. Mainou-Fowler T; Porteous A; Nicolle A; Proctor SJ; Anderson JJ; Summerfield G Int J Oncol; 2008 Jul; 33(1):169-74. PubMed ID: 18575763 [TBL] [Abstract][Full Text] [Related]
15. CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival. Zucchetto A; Benedetti D; Tripodo C; Bomben R; Dal Bo M; Marconi D; Bossi F; Lorenzon D; Degan M; Rossi FM; Rossi D; Bulian P; Franco V; Del Poeta G; Deaglio S; Gaidano G; Tedesco F; Malavasi F; Gattei V Cancer Res; 2009 May; 69(9):4001-9. PubMed ID: 19383907 [TBL] [Abstract][Full Text] [Related]
16. CLL B cells with a bimodal CD38 expression pattern: persistence of bimodal populations despite effective therapy for B-CLL. Pittner BT; Jelinek DF; Kay NE Leukemia; 2004 Jan; 18(1):180-2. PubMed ID: 14523466 [No Abstract] [Full Text] [Related]
17. Is chronic lymphocytic leukemia one disease? Hamblin T Haematologica; 2002 Dec; 87(12):1235-8. PubMed ID: 12495893 [No Abstract] [Full Text] [Related]
18. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia. Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442 [TBL] [Abstract][Full Text] [Related]
19. CD38 on B-cell chronic lymphocytic leukemia cells has higher expression in lymph nodes than in peripheral blood or bone marrow. Jaksic O; Paro MM; Kardum Skelin I; Kusec R; Pejsa V; Jaksic B Blood; 2004 Mar; 103(5):1968-9. PubMed ID: 14976064 [No Abstract] [Full Text] [Related]
20. Expression levels of CD38 on leukemic B cells but not on non-leukemic T cells are comparably stable over time and predict the course of disease in patients with chronic lymphocytic leukemia. Eisele L; Haddad T; Sellmann L; Dührsen U; Dürig J Leuk Res; 2009 Jun; 33(6):775-8. PubMed ID: 18922578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]